Treatment | Exposure time, number of alive J2s (L) and mortality % (M) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
6h | 12h | 24h | 72h | 7 days | ||||||
L | M (%) | L | M (%) | L | M (%) | L | M (%) | L | M (%) | |
(Neg. control) MI+ d. H2O | 31a | - | 31a | - | 31a | - | 29 a | - | 26.33a | - |
(Pos. control) MI + Nemacur | 28ab | 9.67 | 22.33b | 34.40 | 19.66cd | 36.55 | 4cd | 86.2 | 1.33d | 94.93 |
MI+ 12mg L-1 ZNO-NPs | 27.33b | 11.82 | 19.33b | 37.63 | 18.33d | 40.86 | 3d | 89.65 | 0.66d | 97.46 |
MI+8mg L-1 ZNO-NPs | 29.3ab | 5.37 | 20.33b | 27.95 | 22.33c | 27.95 | 8.33c | 71.26 | 5.33c | 79.74 |
MI+6mg L-1 ZNO-NPs | 30.33ab | 2.15 | 29.66a | 4.30 | 26.66b | 13.97 | 22.33b | 22.98 | 12b | 54.43 |
MI+4mg L-1 ZNO-NPs | 30.6ab | 1.07 | 29.66a | 4.30 | 27.66b | 10.75 | 25.66ab | 11.49 | 15.33b | 41.77 |
LSD 0.05 | 3.27 | - | 3.53 | - | 3.05 | - | 4.81 | - | 3.53 | - |